Cargando…
The role of concomitant immunosuppressants in impeding the progression of diabetic retinopathy: A pilot study
PURPOSE: Hallmark of Diabetic Retinopathy (DR) is blood-retinal barrier alteration. Vascular endothelial growth factor (VEGF) and inflammation are involved in the pathogenesis of DR. Anti-VEGFs and lasers are effective in treating DR but have numerous drawbacks, hence the need to develop alternative...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725116/ https://www.ncbi.nlm.nih.gov/pubmed/34708796 http://dx.doi.org/10.4103/ijo.IJO_837_21 |